Presenting a Comprehensive Wrap-Up of the Liver Transplant Study & Exploring Early Insights from the CHILL Trial

8:30 am - Wednesday 24th March 2027

  • Providing a wrap-up of the liver transplant study and its key clinical learnings for engineered Treg therapies in transplantation
  • Sharing emerging safety and feasibility observations from the CHILL trial and their implications for ongoing clinical development
  • Exploring the potential for durable immune tolerance and reduced reliance on conventional immunosuppression

Speakers:

Founder & Vice President - Biology
Quell Therapeutics